Analysis of Outcomes and Adverse Events of Patients Undergoing Radiation Therapy
Launched by DANIEL ZWAHLEN · Jan 1, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how patients feel and what side effects they experience while receiving radiation therapy, a common treatment for cancer. Researchers will analyze patient records from 2000 to 2025 to better understand the outcomes of this treatment and how it affects quality of life. The goal is to gather important information that can help improve care for future patients.
If you're a patient receiving radiation therapy at the Department of Radiation Oncology at the Winterthur Cantonal Hospital, you may be eligible to participate, as long as you are between the ages of 58 and 105 years. Participants in this study will not only contribute to valuable research but may also gain insights into their own treatment. The trial is currently recruiting, so if you're interested, it’s a good idea to ask your healthcare team for more information.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who are being treated with radiotherapy at the Department of Radiation Oncology at the Winterthur Cantonal Hospital
- Exclusion Criteria:
- • No radiotherapy at the Department of Radiation Oncology at the Winterthur Cantonal Hospital \<16 years,\> 105 years
About Daniel Zwahlen
Daniel Zwahlen is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative and rigorous clinical studies. With a focus on collaboration and ethical standards, the organization aims to bridge the gap between scientific discovery and practical application in healthcare. Leveraging a team of experienced professionals, Daniel Zwahlen ensures the highest quality in trial design, execution, and regulatory compliance, fostering an environment that prioritizes patient safety and data integrity. Their mission is to contribute to the development of effective therapies and enhance the understanding of various health conditions, ultimately aiming to transform the landscape of modern medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winterthur, Zurich, Switzerland
Patients applied
Trial Officials
Daniel Zwahlen, MD, MBA
Principal Investigator
Kantonsspital Winterthur KSW
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials